wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26777886-D3CB9DC9-EDF9-4A66-B1F9-5676A3C943C9
Q26777886-D3CB9DC9-EDF9-4A66-B1F9-5676A3C943C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26777886-D3CB9DC9-EDF9-4A66-B1F9-5676A3C943C9
Pembrolizumab: First in Class for Treatment of Metastatic Melanoma
P2860
Q26777886-D3CB9DC9-EDF9-4A66-B1F9-5676A3C943C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26777886-D3CB9DC9-EDF9-4A66-B1F9-5676A3C943C9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2f496e9d7c026bc78e6198dce43544d6a5019f5a
P2860
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma